Injectable Dual-Cross-Linked Hydrogels Enabling Sequential Drug Release for Synergistic Periodontitis Therapy
ACS Applied Materials & Interfaces · 2026-04-08 · 18 (13) · 18838-18853
DOI: 10.1021/acsami.6c01751 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, published online on 2026-03-30. Written by Chang-Hai Zhou and 9 co-authors. Institution: School of Chemical Engineering, Sichuan University, Chengdu 610065, China. Major MEDLINE topics: Hydrogels, Periodontitis, Anti-Bacterial Agents, Metronidazole. Cited 3 times so far (Crossref); 50 references. Funded by: Natural Science Foundation of Sichuan Province, National Natural Science Foundation of China.
Abstract (original language)
Periodontitis, a chronic infectious disease caused by pathogenic bacteria, characterized by a severe host immune response. Combined antimicrobial and anti-inflammatory strategies can enhance therapeutic efficacy, and a critical factor for the therapeutic efficacy of anti-inflammatory drugs is the maintenance of a localized antimicrobial microenvironment. Therefore, the release profiles of antimicrobial and anti-inflammatory drugs directly affect the treatment outcomes of periodontitis. In this study, a double-cross-linked injectable hydrogel with temperature-responsive and dynamic covalent cross-linking properties is developed as a codelivery carrier for antimicrobial and anti-inflammatory drugs, enabling sequential drug release for synergistic periodontitis therapy. This system adapts to the irregular geometry of the periodontal pocket upon injection and subsequently self-reinforces to resist salivary flow. Notably, the antimicrobial drug metronidazole is sustainedly released over the first 7 days to establish an antimicrobial microenvironment. After 12 h, the anti-inflammatory drug metformin is continuously released over 14 days to suppress the inflammatory response and promote periodontal tissue regeneration. The synergistic antibacterial, anti-inflammatory, and regenerative capabilities of the hydrogel are further validated in a rat model of periodontitis. This injectable and self-reinforcing system for locally sequential drug release demonstrates significant potential for the clinical management of periodontitis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Chemical Engineering, Sichuan University, Chengdu 610065, China.
- State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
ORCID profiles: Da-Wei Pan, Zhuang Liu, Wei Wang, Rui Xie, Xiao-Jie Ju, Liang-Yin Chu
Funding
- Natural Science Foundation of Sichuan Province
- National Natural Science Foundation of China
Cite
APA
Zhou, C. H., Gao, Y., Zhou, X. L., Pan, D. W., Liu, Z., Wang, W., Xie, R., Wang, J., Ju, X. J., & Chu, L. Y. (2026). Injectable Dual-Cross-Linked Hydrogels Enabling Sequential Drug Release for Synergistic Periodontitis Therapy. ACS Applied Materials & Interfaces, 18(13), 18838-18853. https://doi.org/10.1021/acsami.6c01751
Vancouver
Zhou CH, Gao Y, Zhou XL, Pan DW, Liu Z, Wang W, et al. Injectable Dual-Cross-Linked Hydrogels Enabling Sequential Drug Release for Synergistic Periodontitis Therapy. ACS Applied Materials & Interfaces. 2026;18(13):18838-18853. doi:10.1021/acsami.6c01751
BibTeX
@article{Zhou2026,
author = {Zhou, Chang-Hai and Gao, Yi and Zhou, Xing-Long and Pan, Da-Wei and Liu, Zhuang and Wang, Wei and Xie, Rui and Wang, Jun and Ju, Xiao-Jie and Chu, Liang-Yin},
title = {Injectable Dual-Cross-Linked Hydrogels Enabling Sequential Drug Release for Synergistic Periodontitis Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {13},
pages = {18838--18853},
doi = {10.1021/acsami.6c01751}
}
EUVIMED